A SUBCUTANEOUSLY ADMINISTERED RNAI THERAPEUTIC (ALN-CC5) TARGETING COMPLEMENT C5 FOR TREATMENT OF PNH AND COMPLEMENT MEDIATED DISEASES: INTERIM PHASE 1 STUDY RESULTS IN HEALTHY VOLUNTEERS
HAEMATOLOGICA(2015)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要